Terminalia engleri
Terminalia engleri · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Terminalia engleri is a medicinal plant that has garnered scientific interest due to its diverse therapeutic potential. Research indicates that decoctions made from its barks possess significant antibacterial and antiulcer activities. The plant contains bioactive compounds such as catechin, syringic acid, and various methyl esters, including 11,14-eicosadienoic acid methyl ester and decanoic acid methyl ester. These chemical constituents offer promise in addressing complex health conditions like Alzheimer's disease and gastric ulcers. Furthermore, its properties are being studied for their effectiveness against the bacterium Helicobacter pylori.
- Synonyms
- Pteleopsis Suberosa
- Common names
- Not available
- Family
- Combretaceae
- Distribution
- Southern America
- Plant Parts
- Not available
Classification
Synonyms
Terminalia engleri is a botanical species that has been documented under various scientific names throughout history. In many taxonomic records, you will find it listed by its synonym, Pteleopsis suberosa. This nomenclatural overlap can sometimes cause confusion for researchers studying its specific characteristics. However, recognizing these synonymous relationships is essential for maintaining accurate botanical databases. Understanding these links ensures that scientists are correctly identifying and studying the same plant across different literature.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Terminalia engleri is a remarkable species that belongs to the vast kingdom Plantae. Within this botanical realm, it is classified under the class Equisetopsida. The plant is a member of the order Myrtales, which helps define its evolutionary lineage. It further belongs to the diverse family Combretaceae, showcasing its unique biological characteristics. Ultimately, this tree is a distinguished representative of the genus Terminalia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Combretaceae |
| Genus | Terminalia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Terminalia engleri is a notable botanical species primarily distributed across the West Tropical Africa region. Its presence is widely documented throughout several key nations, including Benin and Burkina Faso. The plant also thrives within the natural landscapes of Ghana and Guinea. Furthermore, its geographical reach extends into the coastal territories of Guinea-Bissau. This specific distribution highlights the importance of the species within the broader West African ecosystem.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Terminalia engleri is a self-supporting tree characterized by its sturdy growth form. This species reaches a maximum height of approximately 9.14 meters as it matures. Its structural integrity allows it to stand independently within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Terminalia engleri has demonstrated significant therapeutic potential through its dual medicinal properties. Research indicates that this plant possesses notable antibacterial activity, making it a subject of interest for combating various pathogens. Furthermore, the species exhibits effective antiulcer properties that may assist in treating gastric distress. These combined biological activities suggest that the plant could serve as a valuable resource in pharmacological development. Consequently, exploring its chemical constituents may lead to new treatments for infection and digestive ailments.
Compounds
Terminalia engleri is a notable medicinal plant that possesses a diverse profile of bioactive phytochemicals. Research indicates that this species contains several important compounds, including catechin and caffeic acid. Additionally, the plant is characterized by the presence of syringic acid and azelaic acid. Further chemical analysis also reveals that Terminalia engleri contains decanoic acid methyl ester. These specific metabolites contribute to the plant's potential role in providing neuroprotective benefits.
Conditions
Terminalia engleri possesses significant therapeutic potential in the management of various medical conditions. Research indicates that this plant can be used to treat Alzheimer's disease by targeting neuroprotective pathways. It also demonstrates effectiveness in treating Helicobacter pylori, which is a key factor in digestive issues. Furthermore, the plant is capable of treating citric acid-induced cough, providing relief for respiratory distress. Finally, its medicinal properties extend to the treatment of both gastric and duodenal ulcers, including specific gastric ulcers.
Preparations
Terminalia engleri is prepared as barks for medicinal use. This specific plant species is also prepared as a decoction to utilize its therapeutic properties. These preparation methods highlight the practical applications of the plant in traditional medicine. Both the bark and the decoction serve as important forms for administering the plant's components. Consequently, these two preparation styles define how the species is processed for health purposes.